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ABSTRACT
Serotype 1 pneumococci are rarely isolated from
carriers, but are an important cause of pneumo-
coccal invasive disease in many regions of the
world. This report describes the emergence and
expansion of a single serotype 1 lineage (charac-
terised by multilocus sequence type 306) among
healthy carriers attending day-care centres in
Portugal. The prevalence of serotype 1 strains
among all pneumococci increased from 0% in
2001 and 2002, to 0.4% in 2003, and 3.1% in 2006.
These observations paralleled the introduction
and increased use of the seven-valent pneumo-
coccal conjugate vaccine in the study group,
suggesting a direct relationship between these
events.
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Infections caused by Streptococcus pneumoniae
result in significant morbidity and mortality in
children [1]. More than 90 pneumococcal sero-
types have been identified, based on the structure
of the capsular polysaccharide [2], and the
potential of pneumococcal isolates to cause inva-
sive disease has been associated with the capsule
expressed [3]. Serotype 1 is considered to be a
primary pathogen, as it is isolated consistently
from cases of invasive disease and is rarely found
among asymptomatic carriers, even in geograph-
ical areas where it is a dominant cause of
pneumococcal invasive disease [4–7]. Since colo-
nisation precedes disease, it has been proposed
that rarely carried serotypes, e.g., serotype 1, are
poor colonisers because of a short duration of
colonisation and ⁄ or a low density [8].
In the first half of the 20th century, serotype 1
was associated with outbreaks of invasive disease
among adults in the western world [9]. Recent
reports from Africa have described an ongoing
highly lethal epidemic of pneumococcalmeningitis
caused by serotype 1 isolates of the ST217 clonal
complex, as determined by multilocus sequence
typing [10,11]. In Portugal, the rest of Europe and
North America, serotype 1 pneumococcal disease
has been associated with ST306 and its related
sequence types [12,13]. Thepresent studydescribes
the emergence and clonal structure of serotype 1
isolates among Portuguese asymptomatic carriers,
and considers the events that may have led to its
emergence.
Nasopharyngeal samples were obtained from
children attending day-care centres in Lisbon and
Oeiras, Portugal, between January and March in
2001, 2002, 2003 and 2006 (Table 1). The ages of
the children ranged from 4 months to 6 years.
Pneumococci were isolated and identified on the
basis of selective growth on gentamicin blood
agar plates, optochin susceptibility, colony mor-
phology, and a-haemolysis [14]. Capsular typing
was performed by multiplex PCR [15] or, for
those isolates for which the serotype could not be
determined by PCR, the Quellung reaction using
specific antisera (Statens Serum Institute, Copen-
hagen, Denmark). Isolates were tested for suscep-
tibility to erythromycin, clindamycin, tetracycline,
chloramphenicol, co-trimoxazole and levofloxacin
by disk-diffusion following CLSI guidelines [16],
and for penicillin and ceftriaxone by Etest (AB
Biodisk, Solna, Sweden). Pulsed-field gel electro-
phoresis (PFGE) was performed for sero-
type 1 strains as described previously [17], and
a dendrogram was generated using Bionumerics
software (Applied Maths, Sint-Martins-Latem,
Belgium) [18]. Multilocus sequence typing was
performed as described previously [14] for repre-
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sentative isolates of the different PFGE subtypes,
choosing one isolate per collection year. Serotypes
and molecular types of antimicrobial-resistant
pneumococci recovered in 2001, 2002 and 2003
(which did not include any serotype 1 strains)
have been described previously [18,19].
Of 1551 nasopharyngeal samples obtained from
children in 2001 and 2002, 1075 yielded pneumo-
cocci, none of which was of serotype 1 (Table 1).
In 2003, two serotype 1 isolates (representing
0.4% of all pneumococci) were recovered from
two children attending different day-care centres.
In 2006, 12 isolates (3.1% of all pneumococci)
were found to be of serotype 1, and these were
isolated from 12 children attending four day-care
centres (Table 1). The 14 serotype 1 isolates were
fully susceptible to all antimicrobial agents tested.
According to PFGE, they belonged to a single
cluster with two PFGE subtypes (Fig. 1). Accord-
ing to multilocus sequence typing, this cluster
was associated with ST306 and the related ST228
(double-locus variant of ST306), which is found
commonly among serotype 1 disease-causing iso-
lates from Portugal and the rest of Europe [8]. All
children carrying serotype 1 were aged >2 years,
and six had been vaccinated with the seven-valent
pneumococcal vaccine (PCV7). Thus, the emer-
gence of serotype 1 among healthy Portuguese
children in 2003–2006 was associated with a
single pneumococcal lineage that is disseminated
in Europe, and the possibility that the hyper-
virulent pneumococcal clone causing meningitis
in Africa might have been imported into Portugal
was excluded. These findings contrast with data
from Sweden from the 1990s, where the sero-
type 1 lineage emerged as a frequent cause of
invasive disease, but could not be detected among
pneumococcal isolates obtained from children
attending Swedish day-care centres [7].
The present study revealed cross-transmission
within a day-care centre (DCC 22; Fig. 1), but
the serotype 1 clone was also recovered from
children attending four other day-care centres.
The fact that all carriers were aged >2 years
mimicked the age distribution found among
serotype 1 isolates causing invasive disease [8].
Indeed, for unknown reasons, serotype 1 does
not usually cause disease among infants (neonates
excluded). Since all serotype 1 isolates were sus-
ceptible to all antimicrobial agents, the possibility
of selection caused by antimicrobial pressure
could also be excluded.
PCV7 became commercially available in Portu-
gal in June 2001, but is not part of the national
vaccination plan and is not subsidised by the state
[20]. Although there are no official data concern-
ing the use of PCV7 in Portugal, the proportions
of children vaccinated with PCV7 in the study
were 12% in 2002, 24% in 2003, and 64% in 2006
(personal unpublished data). These observations
suggest that the emergence of serotype 1 may
have been related to the impact of PCV7 on
colonisation, which is known to lead to serotype
replacement of vaccine types by non-vaccine
types [21,22]. Whether this emergence resulted
from an unmasking effect or a true clonal expan-
sion is unclear [23].
In conclusion, the present study revealed the
emergence of a serotype 1 lineage of pneumococci
among healthy Portuguese carriers. This
Table 1. Study population and distribution of serotype 1
isolates
Year
Children
sampled
No. of
pneumococcal
isolates
No. of
serotype 1
isolates (%)a
Day-care centres
with serotype 1
isolates
2001 717 465 0 0 ⁄ 11
2002 834 559 0 0 ⁄ 14
2003 766 557 2 (0.4) 2 ⁄ 14
2006 571 392 12 (3.1) 4 ⁄ 12
aPercentage of serotype 1 isolates among all pneumococci.
Fig. 1. Genotypic relationship of
serotype 1 pneumococcal isolates
according to pulsed-field gel
electrophoresis. ST, sequence type;
DCC, day-care centre; PCV7, vacci-
nated with seven-valent pneumo-
coccal conjugate vaccine.
Research Notes 83
 2007 The Authors
Journal Compilation  2007 European Society of Clinical Microbiology and Infectious Diseases, CMI, 14, 82–96
emergence occurred soon after the introduction of
PCV7 use in Portugal, and the increase in
the prevalence of serotype 1 accompanied the
increased use of PCV7. Since this serotype has
been associated with outbreaks of fatal meningitis
and complicated pneumonia, and is not included
in PCV7, it will be important to closely survey the
expansion and evolution of these strains among
healthy carriers, as this group is known to be the
major reservoir of pneumococci.
ACKNOWLEDGEMENTS
SN and RS-L contributed equally to this work. SN was
supported by grants from EURIS (011 ⁄BIC ⁄ 01) and PREVIS
(010 ⁄BIC ⁄ 04), and RS-L was supported by Fundac¸a˜o para a
Cieˆncia e Tecnologia (SFRH ⁄BPD ⁄ 14596 ⁄ 2003 and
SFRH ⁄BPD ⁄ 30871 ⁄ 2006). This work was also supported by
projects EURIS (contract QKL2-CT-2000-01020) and PREVIS
(contract LSHM-CT-2003-503413) from the European Commis-
sion. We thank R. Mato, I. Santos Sanches, A. Brito-Avoˆ,
J. Saldanha, N. Fraza˜o, N. Sousa, C. Simas, I. Criso´stomo,
A. Simo˜es and A. Gonc¸alves for participating in studies that
led to the isolation of the strains described in the study. This
publication made use of the Multilocus Sequence Typing
website (http://www.mlst.net) at Imperial College London,
funded by the Wellcome Trust. The authors have no conflicts
of interest to declare.
REFERENCES
1. Williams BG, Gouws E, Boschi-Pinto C, Bryce J, Dye C.
Estimates of world-wide distribution of child deaths from
acute respiratory infections. Lancet Infect Dis 2002; 2: 25–32.
2. Bentley SD, Aanensen DM, Mavroidi A et al. Genetic
analysis of the capsular biosynthetic locus from all 90
pneumococcal serotypes. PLoS Genet 2006; 2: e31.
3. Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook
DW, Spratt BG. Clonal relationships between invasive and
carriage Streptococcus pneumoniae and serotype- and clone-
specific differences in invasive disease potential. J Infect
Dis 2003; 187: 1424–1432.
4. Hausdorff WP, Bryant J, Kloek C, Paradiso PR, Siber GR.
The contribution of specific pneumococcal serogroups to
different disease manifestations: implications for conjugate
vaccine formulation and use, part II. Clin Infect Dis 2000;
30: 122–140.
5. Porat N, Trefler R, Dagan R. Persistence of two invasive
Streptococcus pneumoniae clones of serotypes 1 and 5 in
comparison to that of multiple clones of serotypes 6B and
23F among children in southern Israel. J Clin Microbiol
2001; 39: 1827–1832.
6. Sjostrom K, Spindler C, Ortqvist A et al. Clonal and cap-
sular types decide whether pneumococci will act as a
primary or opportunistic pathogen. Clin Infect Dis 2006; 42:
451–459.
7. Henriques Normark B, Kalin M, Ortqvist A et al.
Dynamics of penicillin-susceptible clones in invasive
pneumococcal disease. J Infect Dis 2001; 184: 861–869.
8. Hausdorff WP, Feikin DR, Klugman KP. Epidemiological
differences among pneumococcal serotypes. Lancet Infect
Dis 2005; 5: 83–93.
9. Heffron R. Pneumonia with special reference to pneumococcus
lobar pneumonia, 1st edn. Oxford: Oxford University Press,
1939.
10. Leimkugel J, Adams Forgor A, Gagneux S et al. An out-
break of serotype 1 Streptococcus pneumoniae meningitis in
northern Ghana with features that are characteristic of
Neisseria meningitidis meningitis epidemics. J Infect Dis
2005; 192: 192–199.
11. Yaro S, Lourd M, Traore Y et al. Epidemiological and
molecular characteristics of a highly lethal pneumococcal
meningitis epidemic in Burkina Faso. Clin Infect Dis 2006;
43: 693–700.
12. Brueggemann AB, Spratt BG. Geographic distribution and
clonal diversity of Streptococcus pneumoniae serotype 1
isolates. J Clin Microbiol 2003; 41: 4966–4970.
13. Serrano I, Melo-Cristino J, Carric¸o JA, Ramirez M. Char-
acterization of the genetic lineages responsible for pneu-
mococcal invasive disease in Portugal. J Clin Microbiol
2005; 43: 1706–1715.
14. Nunes S, Sa´-Lea˜o R, Carric¸o J et al. Trends in drug resis-
tance, serotypes, and molecular types of Streptococcus
pneumoniae colonizing preschool-age children attending
day care centers in Lisbon, Portugal: a summary of 4 years
of annual surveillance. J Clin Microbiol 2005; 43: 1285–1293.
15. Brito DA, Ramirez M, de Lencastre H. Serotyping Strep-
tococcus pneumoniae by multiplex PCR. J Clin Microbiol
2003; 41: 2378–2384.
16. Clinical and Laboratory Standard Institute. Performance
standards for antimicrobial disk susceptibility tests, approved
standard, 9th edn, documentM2-A9.Wayne, PA:CLSI, 2006.
17. Sa´-Lea˜o R, Tomasz A, Sanches IS et al. Genetic diversity
and clonal patterns among antibiotic-susceptible and
-resistant Streptococcus pneumoniae colonizing children: day
care centers as autonomous epidemiological units. J Clin
Microbiol 2000; 38: 4137–4144.
18. Mato R, Sanches IS, Simas C et al. Natural history of drug-
resistant clones of Streptococcus pneumoniae colonizing
healthy children in Portugal. Microb Drug Resist 2005; 11:
309–322.
19. Sousa NG, Sa´-Lea˜o R, Criso´stomo MI et al. Properties of
novel international drug-resistant pneumococcal clones
identified in day-care centers of Lisbon, Portugal. J Clin
Microbiol 2005; 43: 4696–4703.
20. Lopalco PL. Use of 7-valent pneumococcal conjugate
vaccine in EU. Eurosurveillance 2006; 11: E061207.3.
21. Fraza˜o N, Brito-Avoˆ A, Simas C et al. Effect of the seven-
valent conjugate pneumococcal vaccine on carriage and
drug resistance of Streptococcus pneumoniae in healthy
children attending day-care centers in Lisbon. Pediatr Infect
Dis J 2005; 24: 243–252.
22. Pelton SI, Loughlin AM, Marchant CD. Seven valent
pneumococcal conjugate vaccine immunization in two
Boston communities: changes in serotypes and antimi-
crobial susceptibility among Streptococcus pneumoniae
isolates. Pediatr Infect Dis J 2004; 23: 1015–1022.
23. Lipsitch M. Bacterial vaccines and serotype replacement:
lessons from Haemophilus influenzae and prospects for
Streptococcus pneumoniae. Emerg Infect Dis 1999; 5: 336–345.
84 Clinical Microbiology and Infection, Volume 14 Number 1, January 2008
 2007 The Authors
Journal Compilation  2007 European Society of Clinical Microbiology and Infectious Diseases, CMI, 14, 82–96
